A pilot study using 99mTc to measure lead and platinum in the human kidney Journal Articles uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • A pilot study has been conducted to investigate the hypothesis that the chemotherapeutic drug, cisplatinum, can mobilize skeletal lead. In vivo measurements of lead and platinum in the kidney of chemotherapy patients were performed with the technique of x-ray fluorescence, using 99mTc in a backscatter geometry. The results of the pilot study were inconclusive; the majority of patients exhibited no evidence of kidney lead at the level of system sensitivity, and negligible blood and urine lead levels.


  • Todd, AC
  • Chettle, David
  • Scott, MC
  • Somervaille, LJ
  • Braithwaite, RA
  • Beaney, RP
  • Buxton, EJ

publication date

  • July 1993